2017 -2020 Vice President Non-Clinical Development and Phase 1 @ ObsEva SA
2013 -2017 Senior Director NCD and Phase I @ ObsEva SA
2013 -2014 Consultant @ Oliver Pohl - Scientific Consulting
2011 -2013 Global Project Director and NCD and Phase I Project Director @
2009 -2010 Non-Clinical Development Project Manager @
2006 -2009 Study Director @
2004 -2005 Clinical Study Manager @
2003 -2004 Clinical Research Associate @
Oliver Pohl Education
European Society for Translational Medicine (EUSTM) 2015-2015
European Society for Translational Medicine (EUSTM)/Global Translational Medicine Consortium (GTMC) 2013-2013
Project Management Institute, Inc 2010-2012
University of Vienna, Vienna 2007-2010
Université Paris Sud, Paris 2005-2006
Université Pierre et Marie Curie Paris 2004-2005
Institut of Physiology (LMU) Munich 2000-2003
Ludwig-Maximilians Universität (LMU) Munich 1996-2002
Oliver Pohl Skills
Clinical Pharmacology
Medical Writing
Medicine
Management
Translational Medicine
Molecular Biology
Medical Devices
Project Management
Biochemistry
Validation
Technology Transfer
Therapeutic Areas
Pharmacokinetics
Laboratory
Life Sciences
CRO Management
Marketing
Data Analysis
Strategic Planning
Public Speaking
PowerPoint
Oliver Pohl Summary
Oliver Pohl, based in Geneva, GE, CH, is currently a Director at Novartis. Oliver Pohl brings experience from previous roles at STALICLA and ObsEva SA. Oliver Pohl holds a 2015 - 2015 European Society for Translational Medicine (EUSTM). With a robust skill set that includes Clinical Pharmacology, Medical Writing, Medicine, Management, Translational Medicine and more. Oliver Pohl has 3 emails on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.